Post-transcriptional Regulation of MMP16 and TIMP2 Expression via miR-382, miR-410 and miR-200b in Endometrial Cancer

• Published in: Cancer genomics & proteomics 2017-09, Vol.14 (5), p.389-401
• Main Authors: RAK, BEATA, MEHLICH, DAWID, GARBICZ, FILIP, DOMOSUD, ZOFIA, PASKAL, WIKTOR, MARCZEWSKA, M. JANINA, WŁODARSKI, K. PAWEŁ
• Format: Article
• Language: English
• ISSN: 1109-6535; 1790-6245
• DOI: 10.21873/cgp.20049

Background/Aim: The post-transcriptional regulation of matrix metalloproteinases (MMPs) via microRNAs (miRNAs) has been recently described in numerous human malignancies. However, the exact mechanisms of miRNA-mediated MMPs deregulation in endometrial cancer (EC) remain unclear. Herein, we aimed to analyze the expression of MMP2, MMP16 and TIMP2 and identify miRNAs that modulate their expression. Materials and Methods: Protein expression was assessed by immunohistochemistry in formalin-fixed paraffin-embedded EC samples. Target prediction algorithms were applied to select miRNAs binding the 3’UTRs of MMP16 (miR-377, miR-382, miR-410, miR-200b) or TIMP2 (miR-200b), and their levels were measured by qPCR in laser capture-microdissected tissue fragments. Luciferase assays and western blotting were used to indicate individual miRNA- mRNA interactions. Results: Overexpression of MMP2 and MMP16 in cancerous tissues corresponded to down-regulation of miR-377, miR-382 and miR-410, while decreased expression of TIMP2 was associated with miR-200b up-regulation. In vitro experiments confirmed direct regulation of MMP16 by miR-382 and miR-410, and TIMP2 by miR-200b in EC Ishikawa cells. Conclusion: We demonstrated novel mechanisms of miRNA-mediated regulation of MMPs activity in EC.